| Date Filed | Type | Description |
| 06/29/2023 |
SC 13D/A
| PureTech Health LLC has filed a Schedule 13D for Gelesis Holdings, Inc. |
| 05/30/2023 |
SC 13D/A
| PureTech Health LLC reports a 88.4% stake in Gelesis Holdings, Inc. |
| 05/02/2023 |
SC 13D/A
| PureTech Health LLC reports a 87% stake in Gelesis Holdings, Inc. |
| 04/20/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/04/2023 |
SC 13D/A
| PureTech Health LLC has filed a Schedule 13D for Gelesis Holdings, Inc. |
| 02/23/2023 |
SC 13D/A
| PureTech Health LLC has filed a Schedule 13D for Gelesis Holdings, Inc. |
| 08/12/2022 |
SC 13D/A
| PureTech Health LLC reports a 4.6% stake in Karuna Therapeutics, Inc. |
| 08/09/2022 |
SC 13D/A
| PureTech Health LLC reports a 5.1% stake in Karuna Therapeutics, Inc. |
| 08/04/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/21/2022 |
SC 13D
| PureTech Health LLC reports a 23.6% stake in Gelesis Holdings, Inc. |
| 11/12/2021 |
SC 13D/A
| PureTech Health LLC reports a 5.6% stake in Karuna Therapeutics, Inc. |
| 08/26/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/26/2020 |
SC 13D/A
| PureTech Health LLC reports a 18.1% stake in Karuna Therapeutics, Inc. |
| 05/05/2020 |
SC 13D/A
| PureTech Health LLC reports a 0% stake in resTORbio, Inc. |
| 12/19/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/11/2019 |
SC 13D
| PureTech Health LLC reports a 31.6% stake in Karuna Therapeutics, Inc. |
| 02/09/2018 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |